EGCG impedes human Tau aggregation and interacts with Tau
Abstract Tau aggregation and accumulation is a key event in the pathogenesis of Alzheimer’s disease. Inhibition of Tau aggregation is therefore a potential therapeutic strategy to ameliorate the disease. Phytochemicals are being highlighted as potential aggregation inhibitors. Epigallocatechin-3-gal...
Guardado en:
Autores principales: | Shweta Kishor Sonawane, Hariharakrishnan Chidambaram, Debjyoti Boral, Nalini Vijay Gorantla, Abhishek Ankur Balmik, Abha Dangi, Sureshkumar Ramasamy, Udaya Kiran Marelli, Subashchandrabose Chinnathambi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/05e91abcad094074ac9bbd912436a094 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231
por: Sherif Bayoumy, et al.
Publicado: (2021) -
Tau binding protein CAPON induces tau aggregation and neurodegeneration
por: Shoko Hashimoto, et al.
Publicado: (2019) -
Author Correction: Tau binding protein CAPON induces tau aggregation and neurodegeneration
por: Shoko Hashimoto, et al.
Publicado: (2019) -
Acetylated tau inhibits chaperone-mediated autophagy and promotes tau pathology propagation in mice
por: Benjamin Caballero, et al.
Publicado: (2021) -
Imaging tau pathology in Parkinsonisms
por: Sarah Coakeley, et al.
Publicado: (2017)